Post-earnings recap
Reported
Mon, Jul 27, 2026
EPS actual
$1.92
EPS est.
$1.63
EPS surprise
+17.79%
1-day move
+2.94%
The Ensign Group reported a strong earnings per share figure, beating expectations by nearly 18%. This positive surprise likely contributed to the stock's increase of nearly 3% in response to the earnings announcement. However, without revenue data or management commentary, investors may need to wait for further details to gauge the company's overall performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.92 | N/A | +17.79% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based solely on numerical results.
The Ensign Group, Inc. operates in the health care sector, focusing on providing skilled nursing and rehabilitation services. With a market cap of $11 billion, the company plays a significant role in the health care facilities industry, which is experiencing increased demand due to an aging population and rising health care needs.
Last quarter
In Q1-2026, Ensign Group reported an EPS of $1.85, exceeding expectations by 13.85%. The stock reacted positively, gaining 0.16% the following day.
EPS beat streak
8Q
EPS beat rate
100%
Avg EPS surprise
+13.12%
Avg 1-day reaction
+0.79%
Investors are cautiously optimistic about Ensign Group's upcoming earnings report, especially given its strong track record of beating EPS estimates.
Bull case
If the company continues its trend of beating EPS estimates, it could signal strong operational performance and growth potential, leading to a positive stock reaction.
Bear case
On the other hand, any signs of slowing revenue growth or increased operational costs could raise concerns about the company's future profitability.
The print will turn on these.
Q1
What will the EPS be for Q2-2026, and how does it compare to previous quarters?
Given the company's history of beating EPS estimates, this figure will be crucial in determining market sentiment and stock performance.
Q2
What are the expectations for revenue growth this quarter?
Revenue growth is a key indicator of the company's ability to expand and meet increasing demand in the health care sector.
—
Est. EPS
—
Est. Rev
—
Impl. Move
±16.2%
Why consensus could be wrong
The market may be underestimating the potential for Ensign Group to exceed EPS expectations again, given its consistent track record.
Supporting evidence
The company has a 100% EPS beat rate over the last eight quarters, indicating strong operational performance.
Options pricing suggests a larger move than historical averages, indicating heightened expectations.
Recent trends in the health care sector show increasing demand for skilled nursing services, which could benefit Ensign Group.
Key risk
If the EPS comes in below $1.70, it could challenge the current positive sentiment around the stock.
Pre-commit to what would confirm each case.
The upcoming earnings report will be pivotal in assessing the company's financial health and growth trajectory, especially in light of recent performance trends.
Bull confirmed if
An EPS of $1.90 or higher would confirm strong operational performance and growth.
Bear confirmed if
An EPS below $1.70 could indicate potential issues with profitability and growth.
What the market is pricing for the move.
Implied Move
±4.1%
Historical Avg
±1.3%
The options market is pricing in a potential move of about 4.1%, indicating that traders expect some volatility around the earnings announcement.
Options are pricing ±4.1% while ENSG has averaged ±1.3% over the last 8 prints — setup is pricing rich.
ATM IV
0.3%
30d HV
25.4%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If Ensign Group beats expectations, history suggests the stock could rise by around 0.39% on the following day, confirming strong operational health.
In line / cautious
If results are in line with expectations, the market may react cautiously, leading to minimal movement in the stock price as investors await further guidance.
Miss
A miss on EPS could lead to a decline of around 0.39% or more, as investors reassess the company's growth prospects.
The lines on the call that would change the story.